Logo
x

Search

Subscribe Now

Signs

Marinomed Biotech Signs a License Agreement with Luoxin to Commercialize Budesolv (budesonide nasal spray) in Greater China

Marinomed Biotech Signs a License Agreement with Luoxin to Commercialize Budesolv (budesonide nasal spray) in Greater China

  • October 22, 2021
Sumitomo Dainippon Pharma Signs a Definitive Agreement with BehaVR to Develop and Commercialize PDTs and Wellness Product for CNS Disorders

Sumitomo Dainippon Pharma Signs a Definitive Agreement with BehaVR to Develop and Commercialize PDTs and Wellness Product for CNS...

  • October 21, 2021
Takeda Signs an Agreement with Calithera to Acquire Sapanisertib and Mivavotinib

Takeda Signs an Agreement with Calithera to Acquire Sapanisertib and Mivavotinib

  • October 19, 2021
Ipsen Signs an Exclusive WW Collaboration with Accent to Develop and Commercialize METTL3 Program

Ipsen Signs an Exclusive WW Collaboration with Accent to Develop and Commercialize METTL3 Program

  • October 18, 2021
Takeda Signs an Exclusive License Agreement with Poseida for Novel Non-Viral In Vivo Gene Therapies

Takeda Signs an Exclusive License Agreement with Poseida for Novel Non-Viral In Vivo Gene Therapies

  • October 13, 2021
Spark Signs an Exclusive Global Licensing Agreement with CombiGene for CG01 to Treat Focal Epilepsy

Spark Signs an Exclusive Global Licensing Agreement with CombiGene for CG01 to Treat Focal Epilepsy

  • October 13, 2021
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.